| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.10▼ | 1.13▼ | 1.13▼ | 1.22▼ | 1.12▼ |
| MA10 | 1.11▼ | 1.14▼ | 1.18▼ | 1.19▼ | 0.94▲ |
| MA20 | 1.12▼ | 1.19▼ | 1.24▼ | 1.20▼ | 0.79▲ |
| MA50 | 1.14▼ | 1.25▼ | 1.20▼ | 0.93▲ | 0.84▲ |
| MA100 | 1.19▼ | 1.20▼ | 1.23▼ | 0.80▲ | 1.04▲ |
| MA200 | 1.25▼ | 1.23▼ | 1.12▼ | 0.83▲ | 1.58▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.002▼ | -0.009▼ | -0.022▼ | -0.021▼ | 0.061▲ |
| RSI | 28.182▼ | 19.597▼ | 28.124▼ | 49.163▼ | 62.067▲ |
| STOCH | 19.881▼ | 6.404▼ | 4.628▼ | 37.464 | 67.628 |
| WILL %R | -87.500▼ | -97.368▼ | -97.561▼ | -93.182▼ | -40.845 |
| CCI | -120.479▼ | -117.664▼ | -123.173▼ | -74.252 | 96.035 |
|
Tuesday, March 24, 2026 08:48 AM
Immunic (IMUX) stock jumps as Guggenheim initiates its coverage with a Buy rating and a $7 target, citing its lead asset vidofludimus calcium. Read more here.
|
|
Tuesday, March 24, 2026 08:47 AM
Immunic Inc. (NASDAQ:IMUX) shares rose 7.7% on Tuesday after Guggenheim analyst Yatin Suneja initiated coverage with a Buy rating and a $7.00 price target. The company is developing vidofludimus ...
|
|
Tuesday, March 24, 2026 02:28 AM
Immunic, Inc. is a clinical-stage biopharmaceutical company, which develops a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases. It focuses ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 27/03/26 | 1.24 | 1.25 | 1.095 | 1.10 | 3,305,864 |
| 26/03/26 | 1.30 | 1.31 | 1.23 | 1.26 | 1,580,701 |
| 25/03/26 | 1.26 | 1.35 | 1.26 | 1.32 | 1,989,990 |
| 24/03/26 | 1.19 | 1.29 | 1.19 | 1.25 | 2,471,379 |
| 23/03/26 | 1.15 | 1.20 | 1.12 | 1.17 | 1,822,850 |
| 20/03/26 | 1.15 | 1.16 | 1.07 | 1.10 | 2,013,417 |
| 19/03/26 | 1.14 | 1.18 | 1.11 | 1.16 | 1,400,971 |
| 18/03/26 | 1.20 | 1.21 | 1.15 | 1.15 | 1,197,000 |
| 17/03/26 | 1.15 | 1.215 | 1.11 | 1.20 | 2,811,000 |
| 16/03/26 | 1.18 | 1.2599 | 1.13 | 1.16 | 2,282,972 |
|
|
||||
|
|
||||
|
|